Skip to main content
INVAMED

Paclitaxel-coated PTCA balloon catheter that inhibits restenosis in coronary angioplasty — a stentless option for in-stent restenosis and small vessels.

Last Updated: July 2026

Extender Drug Eluting PTCA Balloon Catheter Paclitaxel

Extender Drug Eluting PTCA Balloon Catheter Paclitaxel

A paclitaxel-coated coronary balloon catheter aimed at reducing restenosis during percutaneous transluminal coronary angioplasty (PTCA), ensuring effective drug delivery to the vessel wall.

Specialties

Interventional Cardiology, Cardiac

Key Features

  • Engineered with advanced drug-coating technology, ensuring uniform and
  • controlled drug delivery to the vessel wall
  • Optimally designed for precise lesion dilation while minimizing vessel wall trauma,
  • providing therapeutic advantages in challenging scenarios
  • Drug incorporated in hydrophilic coating
  • Hydrophilic coating delivers Paclitaxel homogeneous to the vessel wall instantaneously upon contact

Extender Drug Eluting PTCA Balloon Catheters

  • Engineered with advanced drug-coating technology, ensuring uniform and
    controlled drug delivery to the vessel wall

  • Optimally designed for precise lesion dilation while minimizing vessel wall trauma,
    providing therapeutic advantages in challenging scenarios

Precision Treatment, Exceptional Results

  • Drug incorporated in hydrophilic coating

  • Hydrophilic coating delivers Paclitaxel homogeneous to the vessel wall instantaneously upon contact

  • No airborne particles at any time and no premature release of Paclitaxel

  • Paclitaxel is only released when the balloon touches the vessel wall

Elevating PTCA to New Heights

  • No longitudinal growth for controlled expansion, even at high pressures

  • No balloon deformations up to rated burst pressure for precise stent apposition

  • Rapidly and maximally absorbed by the vessel wall

  • Minimized drug loss in bloodstream prior to inflation securing reliable drug dose delivery

  • Load secured to achieve the therapeutic window within 30 seconds inflation time

  • providing an extensive and safe working range

By choosing the Extender Drug-Eluting PTCA Balloon, healthcare professionals are not just choosing a device; they are choosing a solution that brings together the best in medical engineering and pharmacology to provide a comprehensive treatment option. With the Extender Balloon, patients are in good hands, and surgeons are equipped to deliver exceptional care.

EFFORTLESS DELIVERABILITY

By choosing the Extender Drug-Eluting PTCA Balloon, healthcare professionals are not just choosing a device; they are choosing a solution that brings together the best in medical engineering and pharmacology to provide a comprehensive treatment option. With the Extender Balloon, patients are in good hands, and surgeons are equipped to deliver exceptional care.

Proven efficacy in inhibiting restenosis, backed by robust clinical evidence and favorable outcomes

No procedural limitations

  • No change in standard operating procedures and no handling required

  • No pre-dilatation required: Lesion crossing does not influence drug delivery

  • Multiple inflations will not lead to toxic levels

  • Therapeutic window achieved after 30 seconds inflation time

  • Flexibility and characteristics of a normal workhorse PTCA balloon

Highly compliant balloon material ensures optimal contact with the vessel wall for effective drug delivery.

Paclitaxel Drug Coating

  • Localized Drug Delivery: The balloon’s 3.0–3.5 µg/mm² paclitaxel formulation aims to inhibit neointimal hyperplasia, reducing the risk of recurrent stenosis.

  • Optimized Release Profile: Ensures adequate drug transfer upon inflation, without prolonged systemic exposure.

Balloon Dimensions and Range

  • Balloon Diameters: 2.0 mm to 5.0 mm, covering small vessel and large coronary segment needs.

  • Balloon Lengths: 10, 15, 17, 20, 26, and 30 mm, offering tailored lesion coverage based on vessel size and lesion extent.

Rapid Exchange (RX) Shaft Design

  • Easy Wire Management: Facilitates quick guidewire exchanges and precise navigation in branch or distal lesions.

  • Catheter Lengths: 120 cm and 150 cm, adapting to various patient anatomies or access routes (radial/femoral).

Radiopaque Markers

  • RO Marker Bands: Enhance fluoroscopic visibility, aiding in accurate balloon positioning and monitoring during inflation.

Guidewire Compatibility

  • 0.014” Standard: Ensures broad usage with common PCI guidewires, promoting smooth device transitions.

  • Localized Drug Delivery: The balloon’s 3.0–3.5 µg/mm² paclitaxel formulation aims to inhibit neointimal hyperplasia, reducing the risk of recurrent stenosis.

  • Optimized Release Profile: Ensures adequate drug transfer upon inflation, without prolonged systemic exposure.

  • Balloon Diameters: 2.0 mm to 5.0 mm, covering small vessel and large coronary segment needs.

  • Balloon Lengths: 10, 15, 17, 20, 26, and 30 mm, offering tailored lesion coverage based on vessel size and lesion extent.

  • Easy Wire Management: Facilitates quick guidewire exchanges and precise navigation in branch or distal lesions.

  • Catheter Lengths: 120 cm and 150 cm, adapting to various patient anatomies or access routes (radial/femoral).

  • RO Marker Bands: Enhance fluoroscopic visibility, aiding in accurate balloon positioning and monitoring during inflation.

  • 0.014” Standard: Ensures broad usage with common PCI guidewires, promoting smooth device transitions.